Exploring the top 20 biopharma companies Q1 2024 market cap growths
PharmaNewsIntelligence In the midst of economic uncertainties, fluctuating interest rates, and evolving Medicare Drug Price Negotiation policies, the top 20 global biopharmaceutical companies have achieved a promising start to the year. According to a GlobalData report, these companies collectively witnessed a notable increase in market capitalization during the first quarter, with a rise of 9.6% from $3.67...Lilly's market capitalization growth can be attributed to the strong sales performance of Mounjaro, their glucagon-like peptide 1 (GLP-1) drug designed for treating type 2 diabetes. Furthermore, the FDA approval of Zepbound in November 2023, which contains the same active ingredient as Mounjaro but is intended for obesity treatment, has also contributed to Lilly's growth....
More Features
Omnicell launches XT Amplify, amending pharmacy care delivery model
On April 16, 2024, Omnicell, a multinational healthcare technology company, announced the launch of XT Amplify, a multi-year innovation project that aims to optimize the current pharmacy care delivery model by enhancing the existing XT...
Discovering 6 applications of bioinformatics in drug repurposing
Northeastern University defines bioinformatics as a combination of computer programming, big data, and biology that can be applied to identify and understand sequences or patterns in healthcare. According to the National Human Genome...
Evaluating the safety profile of mifepristone
Mifepristone, commonly known as the abortion pill, is a medication used primarily for medically induced abortions as well as the management of Cushing's syndrome and uterine leiomyomas. Since its approval in 2000, mifepristone has been...
Heart devices linked to injuries, deaths receive FDA’s most serious recall
In a recent announcement, the Food and Drug Administration (FDA) revealed that a pair of heart devices, the HeartMate II and HeartMate 3 Left Ventricular Assist System (LVAS), has received the agency's most serious recall classification...
Exploring 5 types of intellectual property protections in pharma
The Journal of Advanced Pharmaceutical Technology & Research defines intellectual property as “any original creation of the human intellect such as artistic, literary, technical, or scientific creation.” Intellectual...
Understanding the environmental impact of the pharmaceutical industry
The pharmaceutical industry is crucial in improving global health by developing and manufacturing life-saving medications. However, it also has a significant environmental impact that cannot be ignored. The Pharmaceutical...
Strategies for engaging, managing KOLs in the pharma industry
Key opinion leaders (KOLs) are healthcare providers (HCPs) and industry leaders who play a critical role in the healthcare industry, acting as vital stakeholders for the sector, including life sciences and pharmaceutical companies....
Addressing muscle loss associated with GLP-1 medication use
Glucagon-like peptide-1 (GLP-1) receptor agonists — also known as GLP-1 drugs — have gained a significant amount of attention in recent years because of their utility in managing type 2 diabetes (T2D) and, even more so, in...
Tailoring medication selection with pharmacogenomic testing
In modern healthcare, pharmacogenomic assessments are helping healthcare providers determine medication selection, ensuring tailored treatment plans for everyone’s unique genetic makeup. Pharmacogenomic Testing Drug–gene...
Comparing inflammatory bowel disease treatment options
Last month, AbbVie sponsored several presentations and posters at the European Crohn's and Colitis Organization’s (ECCO) annual congress. Among these abstracts was the SEQUENCE study, which compared risankizumab and ustekinumab...
Understanding HIV drug resistance, implications for treatment strategies
For HIV treatment, the emergence of drug resistance poses a significant challenge. Despite remarkable advancements in antiretroviral therapy (ART), the persistence of HIV in the body and its ability to mutate presents a constant threat to...
Exploring Transparency-Rx’s pharmacy benefit manager partners
Transparency-Rx is a recently launched organization of transparent pharmacy benefit managers working towards addressing the ongoing challenges with pharmacy benefit managers (PBMs) that have hindered access to care and significantly...
Manufacturing complex pharmaceutical products with new technologies
Scientific advancement and increasingly complex pharmaceutical products have reshaped the healthcare industry, providing novel tools and solutions for managing broad conditions, from acute viral infections to chronic diseases to oncology....
Revolutionizing Vaccine Storage and Distribution with Innovative Solutions
The global COVID-19 pandemic has highlighted the critical role of vaccines in controlling the spread of infectious diseases. As the demand for vaccines continues to rise, developing innovative solutions for their storage and distribution...
Developing Quality Assurance Standards for Biologics, Biosimilars
Biologics and biosimilars are a rapidly growing sector of the biopharmaceutical industry. However, as the field grows, multiple challenges arise in the manufacturing and quality assurance guidelines for biologics and biosimilars....
Continuous Manufacturing Revolutionizes Pharmaceutical Production
In the pharmaceutical sector, continuous manufacturing (CM) has emerged as a transformative technology with the potential to revolutionize the industry. As drugmakers seek to enhance efficiency, reduce costs, and ensure a resilient supply...
Understanding Digital Health Passports in a Post-Pandemic World
According to the National Foundation for Cancer Research (NFCR) — which refers to digital health passports, digital health passes, and vaccine passports interchangeably — digital health passports are a health documentation tool...
Advancing Packaging Technologies for Climate-Adaptive Supply Chains
The global climate crisis poses significant challenges to the biopharmaceutical industry, particularly regarding packaging and temperature control. The increasing unpredictability of weather patterns can lead to fluctuations in temperature...
Senate Report Exposes Big Pharma’s Profiteering at Americans’ Expense
On February 6, 2024, the United States Senate's Health, Education, Labor, and Pensions (HELP) Committee published a Majority Staff Report highlighting the issue of exorbitant drug prices in the United States. It focuses on the business...
